(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl 2,6-bis((2-mercaptoethylamino)methyl)pyridin-4-ylcarbamate

ID: ALA4076225

Chembl Id: CHEMBL4076225

PubChem CID: 102224210

Max Phase: Preclinical

Molecular Formula: C27H44N4O2S2

Molecular Weight: 520.81

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)=CCC/C(C)=C/CC/C(C)=C/COC(=O)Nc1cc(CNCCS)nc(CNCCS)c1

Standard InChI:  InChI=1S/C27H44N4O2S2/c1-21(2)7-5-8-22(3)9-6-10-23(4)11-14-33-27(32)31-24-17-25(19-28-12-15-34)30-26(18-24)20-29-13-16-35/h7,9,11,17-18,28-29,34-35H,5-6,8,10,12-16,19-20H2,1-4H3,(H,30,31,32)/b22-9+,23-11+

Standard InChI Key:  NULBVZOFKZYNHM-PWHNHFILSA-N

Associated Targets(Human)

BXPC-3 (2997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ASPC1 (1310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRAF6 Tbio TNF receptor-associated factor 6 (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 520.81Molecular Weight (Monoisotopic): 520.2906AlogP: 6.09#Rotatable Bonds: 17
Polar Surface Area: 75.28Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.79CX Basic pKa: 8.39CX LogP: 5.22CX LogD: 3.86
Aromatic Rings: 1Heavy Atoms: 35QED Weighted: 0.10Np Likeness Score: 0.29

References

1. Tanaka A, Radwan MO, Hamasaki A, Ejima A, Obata E, Koga R, Tateishi H, Okamoto Y, Fujita M, Nakao M, Umezawa K, Tamanoi F, Otsuka M..  (2017)  A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group.,  27  (16): [PMID:28666734] [10.1016/j.bmcl.2017.06.047]
2. Radwan MO, Koga R, Hida T, Ejima T, Kanemaru Y, Tateishi H, Okamoto Y, Inoue JI, Fujita M, Otsuka M..  (2019)  Minimum structural requirements for inhibitors of the zinc finger protein TRAF6.,  29  (16): [PMID:31272791] [10.1016/j.bmcl.2019.06.050]

Source